•  
  •  
  •  

SomaGenics is a privately held biotech company with offices and laboratories located in Santa Cruz, CA. We specialize in small RNA technologies, including innovative RNAi-based therapeutics using sshRNA molecules, and diagnostics/biomarker detection of small or fragmented RNA, including microRNAs.

learn more

RNA Leaders

We focus on developing novel RNA-centered approaches to addressing unmet medical needs. SomaGenics' research and development has been supported by over $20M in competitive grants and it is our policy to publish the results of our efforts in respected peer-reviewed journals. Our staff includes internationally recognized leaders in RNA research and technology development. Learn more...

more about SomaGenics

Latest from SomaGenics

 

Somagenics Awarded Second NIH Grant to Develop resQ-RNATM Technology to Quantify Fragmented mRNA From Degraded Samples

SANTA CRUZ, Calif., February 9, 2016 – Somagenics has been awarded a second phase I SBIR grant from NIH to develop its resQ-RNA technology for quantitative real-time PCR of fragmented RNA...

Read more

SomaGenics launches miR-ID® platform for highly sensitive and specific quantification of microRNAs (miRNAs)

SANTA CRUZ, Calif., October 6, 2015- SomaGenics, Inc. today announced the launch of its novel miR-ID® platform for detecting miRNA using a circularization-based RT-qPCR method.  miR-ID® is highly sensitive, uses single-dye...

Read more